Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

Jul 12, 2024

Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, including the following topics:

  • Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00)
  • Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Phillips (18:13)
  • Current and Future Role of Bispecific Antibodies in Follicular Lymphoma and Other B-Cell Lymphomas — Dr Flinn (41:20)
  • Tolerability and Other Practical Considerations with the Use of Bispecific Antibody Therapy — Dr Brody(50:49)

CME information and select publications